risedronic acid has been researched along with Osteolysis in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Osteolysis: Dissolution of bone that particularly involves the removal or loss of calcium.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hamada, H | 1 |
Matsuo, A | 1 |
Koizumi, T | 1 |
Satomi, T | 1 |
Chikazu, D | 1 |
Mundy, GR | 1 |
1 review available for risedronic acid and Osteolysis
Article | Year |
---|---|
Bisphosphonates as cancer drugs.
Topics: Antineoplastic Agents; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Neoplasm Proteins; Ne | 1999 |
1 other study available for risedronic acid and Osteolysis
Article | Year |
---|---|
A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography.
Topics: Administration, Intravenous; Administration, Oral; Alendronate; Alveolar Process; Bisphosphonate-Ass | 2014 |